Back to UBS Group AG UBS Group AG

KYMRKYMR
Showing 8 of 24 quarters

Position history for UBS Group AGUBS Group AG's holdings in KYMERA THERAPEUTICS INC

UBS Group AG holds 1M shares of KYMR (KYMERA THERAPEUTICS INC), worth $115.6M as of 2026-Q2. The position was decreased (-1.6% shares). KYMR represents 0.0% of UBS Group AG's portfolio.

Current Value

$115.6M

Current Shares

1M

Total Value Change

+$105.3M

Total Shares Change

+790,158

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1M
-1.6%
$115.6M0.0%$114.67
0
2026-Q1
Increased
1M
+38.9%
$85.3M0.0%$86.35
39
2025-Q4
Increased
737,032
+13.6%
$57.3M0.0%$78.12
33
2025-Q3
Increased
648,718
+16.3%
$36.7M0.0%$58.50
34
2025-Q2
Decreased
557,734
-6.0%
$24.3M0.0%$44.12
0
2025-Q1
Increased
593,606
+26.3%
$16.2M0.0%$29.62
35
2024-Q4
Increased
469,842
+115.9%
$18.9M0.0%$39.32
46
2024-Q3
Increased
217,619
+3.5%
$10.3M0.0%$48.69
29

Other major holders of KYMR: FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used